As of 2025-04-26, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 1.75 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.77 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -36.9%.
The range of the Relative Valuation is 0.65 - 2.85 CAD.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 25.8x | 25.1x |
| Forward P/E multiples | 25.9x - 45.0x | 28.7x |
| Fair Price | 0.65 - 2.85 | 1.75 |
| Upside | -76.5% - 2.9% | -36.9% |
| Date | P/E |
| 2025-04-24 | 25.09 |
| 2025-04-23 | 23.55 |
| 2025-04-22 | 23.28 |
| 2025-04-21 | 22.82 |
| 2025-04-17 | 23.09 |
| 2025-04-16 | 21.28 |
| 2025-04-15 | 21.55 |
| 2025-04-14 | 20.20 |
| 2025-04-11 | 19.20 |
| 2025-04-10 | 19.20 |
| 2025-04-09 | 20.11 |
| 2025-04-08 | 18.48 |
| 2025-04-07 | 19.65 |
| 2025-04-04 | 19.47 |
| 2025-04-03 | 20.83 |
| 2025-04-02 | 22.28 |
| 2025-04-01 | 22.55 |
| 2025-03-31 | 21.92 |
| 2025-03-28 | 21.74 |
| 2025-03-27 | 22.64 |
| 2025-03-26 | 23.46 |
| 2025-03-25 | 23.00 |
| 2025-03-24 | 23.73 |
| 2025-03-21 | 24.45 |
| 2025-03-20 | 25.09 |
| 2025-03-19 | 23.09 |
| 2025-03-18 | 22.37 |
| 2025-03-17 | 23.09 |
| 2025-03-14 | 23.00 |
| 2025-03-13 | 23.28 |
| 2025-03-12 | 23.46 |
| 2025-03-11 | 23.28 |
| 2025-03-10 | 22.73 |
| 2025-03-07 | 23.91 |
| 2025-03-06 | 23.91 |
| 2025-03-05 | 24.36 |
| 2025-03-04 | 24.00 |
| 2025-03-03 | 23.73 |
| 2025-02-28 | 25.54 |
| 2025-02-27 | 24.63 |
| 2025-02-26 | 26.08 |
| 2025-02-25 | 24.91 |
| 2025-02-24 | 26.99 |
| 2025-02-21 | 25.99 |
| 2025-02-20 | 27.08 |
| 2025-02-19 | 27.44 |
| 2025-02-18 | 27.17 |
| 2025-02-14 | 27.99 |
| 2025-02-13 | 28.44 |
| 2025-02-12 | 28.26 |